Adán Pinto-Fernández
Impact in
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Cancer-related Molecular Pathways
Papers in
-
- Ubiquitin and proteasome pathways 25
- Protein Degradation and Inhibitors 4
- Histone Deacetylase Inhibitors Research 4
- Mitochondrial Function and Pathology 3
- Muscle Physiology and Disorders 3
- Oncology 10
- Peptidase Inhibition and Analysis 7
- Co-authors
- Benedikt M. Kessler (27 shared papers)Andreas Damianou (5 shared papers)Sarah Bonham (3 shared papers)Paul Elliott (3 shared papers)Román Fischer (3 shared papers)Daniel Krappmann (2 shared papers)Hidde L. Ploegh (3 shared papers)Farid El Oualid (2 shared papers)
- Journals
- Nature Communications (3 papers)Life Science Alliance (2 papers)Nature Immunology (2 papers)Molecular & Cellular Proteomics (2 papers)Frontiers in Chemistry (2 papers)
- Partner nations
- United KingdomNetherlandsUnited States
In The Last Decade
Adán Pinto-Fernández
31 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 84
- Molecular Biology 874
- Oncology 313
- Immunology 176
- Epidemiology 210
- Cancer Research 90
Countries citing papers authored by Adán Pinto-Fernández
This map shows the geographic impact of Adán Pinto-Fernández's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adán Pinto-Fernández with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adán Pinto-Fernández more than expected).
Fields of papers citing papers by Adán Pinto-Fernández
This network shows the impact of papers produced by Adán Pinto-Fernández. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adán Pinto-Fernández. The network helps show where Adán Pinto-Fernández may publish in the future.
Co-authors
The 25 scholars most cited alongside Adán Pinto-Fernández, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 372 | |
| 2 | 2021 | 106 | |
| 3 | 2020 | 100 | |
| 4 | 2016 | 57 | |
| 5 | 2019 | 45 | |
| 6 | 2020 | 44 | |
| 7 | 2019 | 42 | |
| 8 | 2020 | 35 | |
| 9 | 2017 | 32 | |
| 10 | 2020 | 32 | |
| 11 | 2020 | 30 | |
| 12 | 2018 | 29 | |
| 13 | 2023 | 28 | |
| 14 | 2020 | 27 | |
| 15 | 2023 | 24 | |
| 16 | 2023 | 15 | |
| 17 | 2021 | 14 | |
| 18 | 2023 | 14 | |
| 19 | 2019 | 13 | |
| 20 | 2024 | 12 |
About Adán Pinto-Fernández
Adán Pinto-Fernández is a scholar working on Molecular Biology, Oncology, Immunology, Cell Biology and Cancer Research, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (25 papers), Peptidase Inhibition and Analysis (7 papers), interferon and immune responses (7 papers), Protein Degradation and Inhibitors (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Autophagy in Disease and Therapy (4 papers), Mitochondrial Function and Pathology (3 papers) and Muscle Physiology and Disorders (3 papers). The work is most often cited by research in Molecular Biology (874 citations), Oncology (313 citations), Immunology (176 citations), Epidemiology (210 citations) and Cancer Research (90 citations). Adán Pinto-Fernández has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include Benedikt M. Kessler, Andreas Damianou, Sarah Bonham, Paul Elliott, Román Fischer, Daniel Krappmann, Hidde L. Ploegh, Farid El Oualid, David Komander and Philip D. Charles. Their work appears in journals such as Nature Communications, Life Science Alliance, Nature Immunology, Molecular & Cellular Proteomics and Frontiers in Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.